Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tryptase as a Biomarker of Coronary Heart Disease

NCT01618279 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.

NCT NCT01618279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01618279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tryptase as a Biomarker of Coronary Heart Disease
Lead sponsor
Niguarda Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2022
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome with st elevation on electrocardiogram, acute coronary syndrome without st elevation on electrocardiogram, aortic aneurysms, noncritical coronary artery disease coronary stenosis less than 50 per cent